Skip to content
›
›
TCM Oncology
Clinical Research

Traditional Chinese Medicine Oncology Specialty

Specialty team led by principal investigator Liu Hanju: research focus, team composition and operating procedures.

TCM Oncology Specialty

Principal investigator: Liu Hanju

Lung cancerLiver cancerEsophageal & gastric cancerBreast cancerPancreatic cancerColorectal & gynecologic cancerCancer pain

The Oncology Department is one of Hebei Yiling Hospital's key specialties and a key TCM specialty construction unit in Shijiazhuang. It draws on the core of traditional Chinese medicine and combines it with modern precision testing and treatment techniques, with a team of senior specialists including chief physicians, associate chief physicians and master's degree holders.

Guided by collateral disease theory, the department practices integrated Chinese and Western medicine organized around a "ten-character" principle — integrated, synergistic, targeted, minimally invasive and green — delivered through a six-part model:

  1. Collateral-unblocking anti-cancer herbal medicine
  2. Tumor interventional therapy
  3. TCM-specific techniques
  4. Immunotherapy
  5. Individualized treatment
  6. Psychological counseling

Herbal medicine is combined with the WHO three-step analgesic ladder for pain management. The department reports minimal trauma, few complications, low toxicity, high efficacy and lower overall costs, with good results in common cancers such as lung, liver, esophageal, breast, pancreatic, gastric, gynecologic and bladder cancers.

Services: traditional Chinese herbal medicine therapy, chemotherapy, interventional minimally invasive therapy, immunotherapy, deep tumor hyperthermia, focused ultrasound ablation, radiofrequency ablation, particle (seed) implantation, and esophageal and airway stent placement. A palliative care ward is in operation, and the team is skilled in tumor biopsy and pathological examination, bone marrow puncture, pericardial and thoracic/abdominal closed drainage, and PICC and subclavian vein catheterization.

About the principal investigator: Liu Hanju

Expertise: using the ten-character approach and six-part model to treat lung, liver, esophageal, gastric, pancreatic, colorectal and gynecologic malignancies, as well as cancer pain.

Principal investigator

Liu Hanju

Chief TCM Physician

Honorary Vice President of Hebei Yiling Hospital and Director of the Oncology Department; trained under Hua Baojin, former president of Guang'anmen Hospital, China Academy of Chinese Medical Sciences.

  • Member, Oncology Branch, China Association of Chinese Medicine
  • Council member (2nd Council), Collateral Disease Professional Committee, World Federation of Chinese Medicine Societies
  • Standing committee member, Hebei Integrated Chinese-Western Medicine Oncology Professional Committee
  • Member, Chinese Society of Clinical Oncology (CSCO) and American Society of Clinical Oncology (ASCO)
  • Standing editorial board member, Chinese Journal of Medical Practice
Research team
Principal investigators2
Investigators9
Research nurse managers1
Research nurses6
Work systems, SOPs & emergency plans46

Planning a clinical trial with us?

Contact the Drug Clinical Trial Institution Office, 4th floor, Outpatient Building, 385 Xinshi North Road, Shijiazhuang. Reception hours: weekdays 8:30–11:30 and 14:00–17:00.